Evaluation of the Efficacy and Safety of Three Injectable Hyaluronic Acid-based Fillers: Art Filler® Fine Lines, Art Filler® Universal and Art Filler® Lips
AF4
1 other identifier
interventional
232
1 country
1
Brief Summary
The function of injectable fillers for the treatment of dermal contour deformities is to smooth dermal depressions formed by the loss of volume and the aging process. These fillers (also known as soft tissue augmentation medical devices) can correct the skin depressions/wrinkles, balance the disproportions or correct topographical anomalies. In this context, it is proposed to carry out in post-CE marking, an open, prospective and non-comparative study in order to document an adequate aesthetic correction of the most frequent areas treated with Art Filler Fine Lines, Art Filler Universal and Art Filler Lips as well as their immediate and long-term tolerance.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 12, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 4, 2019
CompletedFirst Submitted
Initial submission to the registry
November 23, 2020
CompletedFirst Posted
Study publicly available on registry
December 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 21, 2021
CompletedMarch 8, 2022
March 1, 2022
3 months
November 23, 2020
March 7, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Correction on D21 assessed with the global clinical aesthetic score
Objectively measure the improvement according to a global Aesthetic clinical scoring from D0 to D21 of * after injection of Art Filler Fine lines * forehead wrinkles (at least 30 subjects) * upper lip wrinkles (at least 30 subjects) * cheek folds (at least 30 subjects) * crow's feet wrinkles (30 subjects) * after injection of Art Filler Universal * lips volume (at least 30 subjects) * nasolabial folds alone or with marionette wrinkles (at least 30 subjects) * after injection of Art Filler Lips * lips volume (at least 30 subjects) * Very deep nasolabial folds alone or with marionette wrinkles (at least 30 subjects)
D21 (21 days after the injections)
Study Arms (8)
Art Filler Fine Lines (forehead)
EXPERIMENTALInjection of Art Filler Fine Lines in Forehead wrinkles
Art Filler Fine Lines (upper lip)
EXPERIMENTALInjection of Art Filler Fine Lines in upper lip wrinkles
Art Filler Fine Lines (cheek folds)
EXPERIMENTALInjection of Art Filler Fine Lines in cheek folds
Art Filler Fine Lines (crow's feet)
EXPERIMENTALInjection of Art Filler Fine Lines in crow's feet
Art Filler Universal (lips volume)
EXPERIMENTALInjection of Art Filler Universal in lips
Art Filler Universal (nasolabial folds)
EXPERIMENTALInjection of Art Filler Universal in nasolabial folds
Art Filler Lips (lips volume)
EXPERIMENTALInjection of Art Filler Lips in lips
Art Filler Lips (very deep nasolabial folds)
EXPERIMENTALInjection of Art Filler Lips in very deep nasolabial folds
Interventions
The function of injectable fillers for the treatment of dermal contour deformities is to smooth dermal depressions formed by the loss of volume and the aging process. These fillers (also known as soft tissue augmentation medical devices) can correct the skin depressions/wrinkles, balance the disproportions or correct topographical anomalies.
Eligibility Criteria
You may qualify if:
- Subjects who had signed a written informed consent
- Man or Woman aged ≥ 19 years old
- Subject having a Fitzpatrick Phototype I to IV
- Subject having a score of ≥ 1 in the Global aesthetic scale scoring system on at least one area of interest (forehead wrinkles, upper lip wrinkles, cheek folds, crow's feet wrinkles, nasolabial folds and/or marionette wrinkles) and/or ≤ 2 for the lip volume
- Subject having at least one of the following scales by clinical scoring
- For subjects injected by Art Filler Fine Lines:
- a grade ≥ 3 and ≤ 6 on the upper lip wrinkles scale from Bazin
- a grade ≥ 3 and ≤ 5 on the cheek folds scale from Bazin
- For women :
- a grade ≥ 2 and ≤ 5 on the forehead wrinkles scale from Bazin
- a grade ≥ 2 and ≤ 6 on the crow's feet wrinkles scale from Bazin
- For men :
- a grade ≥ 2 and ≤ 6 on the forehead wrinkles from Bazin
- a grade ≥ 2 and ≤ 6 on the crow's feet wrinkles from Bazin
- For subjects injected by Art Filler Universal:
- +9 more criteria
You may not qualify if:
- Subject deprived of freedom by an administrative or legal decision
- Subject who has received indemnification of 4500 € during the 12 previous months for his/her participation in clinical trials (including participation in this study).
- Subject who had facial injections/implants of any non-absorbable fillers in her/his whole life.
- Subject who had laser sessions for skin rejuvenation or laser resurfacing during the 12 previous months or a surgical facelift during the 2 years before the study.
- Subject with a history of facial aesthetic injection (hyaluronic acid within the previous year, botulinum toxin within the last 6 months and long-term temporary injectable implants (semi-permanent implants) within the previous 2 years).
- Subject with a skin-retaining device on the face (mesh, gold wire, liquid silicone or other particulate material).
- Subject who underwent a non-invasive rejuvenation method such as moderate to deep peeling, ultrasound, radiofrequency devices or lasers within the last 6 months.
- Subject with a history of severe multiple allergies or anaphylactic shock.
- Subject with a known hypersensitivity to hyaluronic acid, Lidocaine and/or other components of Art Filler Fine Lines®, Art Filler Universal® and Art Filler Fine Lips® solutions.
- Subject with a known hypersensitivity to chlorhexidine.
- Subject with a known hypersensitivity to lidocaine or local amide anesthetics.
- Subject tending to develop inflammatory skin diseases or hypertrophic scars.
- Subject with a history of streptococcal disease (recurring angina, rheumatic fever).
- Subject with oral or injectable corticoid treatment (or not stopped for at least 3 months). Inhaled corticoids are permitted as well as topical corticotherapy not involving the head or the neck.
- Subjects with any concomitant treatment (or not stopped for at least a year) by immunosuppressant or chemotherapy.
- +8 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dr Mihai Gorj
Paris, 75116, France
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Ferial Fanian, MD
Laboratoires FILLMED
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 23, 2020
First Posted
December 1, 2020
Study Start
April 12, 2019
Primary Completion
July 4, 2019
Study Completion
December 21, 2021
Last Updated
March 8, 2022
Record last verified: 2022-03
Data Sharing
- IPD Sharing
- Will not share